NewswireToday - /newswire/ -
Holmes Chapel, Cheshire, United Kingdom, 2010/04/22 - Prism Ideas, announced that it has been awarded a Queen’s Award for Enterprise 2010.
Prism Ideas, a leading independent provider of medical communications and drug development consultancy services, today announced that it has been awarded a Queen’s Award for Enterprise 2010 in the International Trade category for its outstanding growth in overseas markets. The award sees Prism recognised as one of the UK’s fastest growing international medical communications providers following a significant increase in export sales to international markets. Prism’s success has resulted in a remarkable 169% rise in the company’s overseas sales over the past three years.
The Queen’s Award for Enterprise is the most prestigious and widely recognised corporate accolade for UK industry. The International Trade category acknowledges companies that have demonstrated a major increase in overseas earnings. The award honors Prism’s phenomenal growth in the supply of its complete range of medical communications and drug development consultancy services to international markets.
Combining both commercial and clinical expertise, Prism’s unique range of drug development and medical communications services cover clinical programme consultancy, clinical trial support and medical marketing. Prism works from the conception of clinical plans, throughout the clinical evaluation phase and into post-marketing activities. Prism’s in-house scientific expertise, including specialist pharmaceutical physicians, enable the company to link research activities with the medical communications services necessary to achieve success for its clients.
Peter Cook, CEO and managing director of leading anti-infective drug development company, Biota comments, “I congratulate the whole team at Prism for this award in recognition of their outstanding growth over the past three years. As a Prism customer, the company offers us the expertise in clinical development and commercialisation crucial to helping us achieve our goals. I am confident that the company will continue to enjoy great success over the coming years and look forward to working with the team in the future.”
“Prism is delighted to have been selected for a Queen’s Award for Enterprise” comments Dr. James Sawyer MFPM, CEO of Prism. “The team has worked relentlessly to develop an innovative approach to exporting the company’s services to the international pharmaceutical industry and this is a real testament to the commitment of our employees and their thorough understanding of the industry. We have experienced tremendous growth over the past three years both in term of sales and locations, opening up a new office in Switzerland and with plans to expand to the U.S. this year. This independent and very prestigious endorsement of our achievements has instilled pride throughout the organisation.”
For further information about Prism Ideas, please call +44 (0) 1270 621 724
About Prism Ideas
Prism Ideas (prismideas.com) is an independent company providing drug development consultancy and expert medical affairs support to the pharmaceutical industry. The company offers a full range of medical communications services including congress materials, journal articles, publication plans, advisory boards and advocacy development; drug development consultancy and expert medical support throughout the clinical evaluation drugs from medical monitoring of early stage clinical studies through to post-marketing activities.
Prism’s knowledge of industry, together with a thorough understanding of the science, ensures that clinical trials and medical communications maintain the highest scientific quality whilst meeting the needs of the pharmaceutical industry.
Prism currently has offices in the UK and Switzerland with plans to open a U.S office during 2010.